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Abstract
Primary biliary cirrhosis (PBC) is an autoimmune chronic cholestatic liver disease with a strong
genetic susceptibility due to the high concordance in monozygotic (MZ) twins and a striking
female predominance. Women with PBC manifest an enhanced X monosomy rate in peripheral
lymphocytes and we thus hypothesized an X chromosome epigenetic component to explain PBC
female prevalence. While most genes on the female inactive X chromosome are silenced by
promoter methylation following X chromosome inactivation (XCI), approximately 10% of X-
linked genes exhibit variable escape from XCI in healthy females. This study was designed to test
the hypothesis that susceptibility to PBC is modified by one or more X-linked gene with variable
XCI status. Peripheral blood mRNA and DNA samples were obtained from a unique cohort of MZ
twin sets discordant and concordant for PBC. Transcript levels of the 125 variable XCI status
genes were determined by quantitative RT-PCR analysis and two genes (CLIC2 and PIN4) were
identified as consistently downregulated in the affected twin of discordant pairs. Both CLIC2 and
PIN4 demonstrated partial and variable methylation of CpG sites within 300 bp of the
transcription start site that did not predict the XCI status. Promoter methylation of CLIC2
manifested no significant difference between samples and no significant correlation with transcript
levels. PIN4 methylation showed a positive trend with transcription in all samples but no
differential methylation was observed between discordant twins. A genetic polymorphism
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affecting the number of CpG sites in the PIN4 promoter did not impact methylation or transcript
levels in a heterozygous twin pair and showed a similar frequency in independent series of
unrelated PBC cases and controls. Our results suggest that epigenetic factors influencing PBC
onset are more complex than methylation differences at X-linked promoters and variably
inactivated X-linked genes may be characterized by partial promoter methylation and biallelic
transcription.
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Introduction
Clinical features of different autoimmune disease share more commonalities than
differences including late onset, heritability, and female predominance1. Primary biliary
cirrhosis (PBC) is characterized by progressive destruction of intrahepatic bile ducts, high-
titer serum anti-mitochondrial antibodies (AMA) and circulating autoreactive T cells2.
Similar to most autoimmune diseases, PBC manifests a 10:1 female predominance3 with a
possible involvement of sex chromosomes4, as suggested by the preferential X chromosome
loss observed in peripheral lymphocytes from women with PBC despite random X
chromosome inactivation5, 6. Despite a 50–100 fold higher risk for PBC among first degree
relatives, the incomplete disease concordance among monozygotic (MZ) suggests that PBC
results from combined effects of genetics and the environment2, 7. Epigenetic modifications,
particularly DNA methylation, have been shown to differ between MZ twins8 and appear as
ideal candidates to explain the environmental influence on individual susceptibility to
complex diseases such as PBC.
In females, the inactivation of one parental X chromosome is caused by epigenetic
mechanisms, primarily promoter DNA methylation and histone modifications, resulting in
dosage compensation. Of particular interest are the approximately 125 different X-linked
genes that comprise almost 10% of the X chromosome and exhibit widely variable patterns
of X chromosome inactivation (XCI) between healthy female individuals9. We therefore
hypothesized that PBC susceptibility could be influenced by epigenetic differences of
specific genes on the X chromosome, either by protective genes being silenced or
susceptibility X chromosome genes variably escaping XCI.
In this study we investigated a unique cohort of MZ twins discordant or concordant for PBC
for transcription differences of 125 X chromosome genes and the promoter methylation
patterns of consistently differentially expressed genes. Two genes CLIC2 and PIN4 had
consistently decreased transcript levels in the PBC-affected twins compared to healthy
twins. Bisulfite sequencing of CLIC2 and PIN4 promoter regions revealed both genes to
show partially variable methylation patterns that did not separate into active versus inactive
alleles and did not significantly correlate with transcript levels. These results provide two
novel genes that may be relevant to understanding PBC pathogenesis and suggest that
additional epigenetic studies outside of the promoter regions are needed to understand the
differential transcript levels between MZ twin pairs.
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Peripheral blood samples were collected and processed from 5 MZ twin sets (one
concordant and 4 discordant for PBC) identified in our previous study 7. The age and pairing
of the utilized subjects are illustrated in Table 1. Genomic DNA from whole blood was
isolated using Qiagen Blood Mini kits (Qiagen, Valencia, CA) while Tempus tubes (Applied
Biosystems, Foster City, CA) were utilized and mRNA isolated using an automated ABI
6100 Nucleic Acid PrepStation. Obtained mRNA was then translated into cDNA using
previously described methods10. We used internal quality control thresholds obtained with
species specific TaqMan assays to assess the quality of bulk samples. Stored DNA samples
from 114 female patients with PBC and 118 age-matched controls, and 20 discordant pairs
of sisters of similar age (within 5 years) were utilized for single nucleotide polymorphism
(SNP) analysis. The protocol was approved by the IRB of the University of California at
Davis and all subjects provided written informed consent.
Transcription analysis—RNA was extracted using a 6100 Nucleic Acid PrepStation
(Applied Biosystems) according to the manufacturer’s instructions. The cDNA was
synthesized as described in Clay et al 10. Real time (RT)-PCR was performed at the Lucy
Whittier Molecular & Diagnostic Core Facility at UC Davis using Applied Biosystem
TaqMan 384 low density arrays custom-designed to include primers for the 125
differentially inactivated genes, 5 housekeeping genes to maximize reliability (18S, B2M,
GAPDH, HPRT1, RPLPO), and 3 copies of each of the internal controls androgen receptor
(AR – fully inactivated) and XIST (fully escaping XCI). The assays were designed using AB
Primer Express Software 3.0 with the sequences from the listed genebank accession
numbers (Supplementary Table 1). Each PCR reaction contained 20X primers and probe for
the respective TaqMan ® system with a final concentration of 400 nM for each primer and
80 nM for the TaqMan ® probe and commercially available PCR mastermix (Applied
Biosystems) containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl2, 2.5 mM
deoxynucleotide triphosphates, 0.625 U AmpliTaq Gold DNA polymerase per reaction, 0.25
U AmpErase UNG per reaction and 5 µl of the diluted cDNA sample in a final volume of 12
µl. The samples were placed in a 384 well plate and amplified in an automated fluorometer
(ABI PRISM 7900 HTA FAST, ABI). ABI’s standard amplification conditions were used: 2
min at 50 °C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C and 60 s at 60 °C. Control wells
without reverse transcriptase were included. Fluorescent signals were collected during the
annealing temperature and CT values for were exported with a threshold of 0.06 and a
baseline of 3–15 for the genes of interest. The intra-assay coefficient of variation of the
threshold cycle (CT) ranged from 0.1 to 3%. Final quantitation was done using the
comparative Ct method, and is reported as relative transcription or the n-fold difference
relative to a calibrator cDNA. In brief, the weakest expressing housekeeping gene, beta2-
microglobin (B2M), was used to normalize the Ct values of the target genes (ΔCT). The
ΔCT was then calibrated against the average of the healthy control for each target gene. The
relative linear amount of target molecules relative to the calibrator, was calculated by 2
elevated to the absolute value of ΔΔCt. Therefore, all gene transcription is expressed as an
n-fold difference relative to the calibrator. The linearized value of the calibrator is 1. Eleven/
125 analyzed genes did not provide sufficient amplification to obtain transcription data; only
genes for which at least 3 twin pairs provided transcripts were included for consistency
comparisons (genes not fulfilling this criterion are highlighted in Supplementary Table 2).
Bisulfite sequencing of PIN4, CLIC2 and AR—Bisulfite treatment of 500 ng of
gDNA from each sample was performed using the Zymo Methylation Direct Kit (Zymo
Research) following manufacturer’s instructions. Converted DNA was stored at −20°C until
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used. Converted bisulfite DNA was PCR amplified using primers for the promoter regions
of CLIC2, PIN4 and AR designed by online MethPrimer software
(http://www.urogene.org/methprimer/index.html)11. Primers for were as follows: CLIC2
(Figure 1a) F: CTCAATCT CAGGGTCCACTTGAGTGC, R: CCAAAGGGGTGT
GTATAAACTGCCTGG; PIN4 (Figure 2a) F: GTCTGCCCCAAGCTGTGCCTGCTTC, R:
GAAGGGAGGGAACAGACAGTCC ATCT; AR F: GAGCT TTCCAGAATCTGTT
CCAGAG, R: TAGAGGCCCCACAGGCTACCTGGTC. These primers were designed to
regions without CpG sites to avoid amplification bias of methylated versus unmethylated
sequences. PCR products were purified using a gel extraction kit (Qiagen, Valencia, CA)
and then cloned into a pGEM-T easy plasmid and JM109 competent cells (Promega). Using
blue/white color screening on ampicillin plates, 20 white transformed colonies from each
sample and each PCR amplicon were sequenced and analyzed for the percentage of
methylated cytosine at each sample.
PIN4 genotyping—The PIN4 coupled polymorphism that removes two adjacent CpG sites
is designated as SNP: ss10563357 (Rs7058353) according to NCBI dbSNP. Primers for
PIN4 genotyping were designed using Primer3 online software F:
CAGACATCTTCAGCCCCATT, R:CTCTACCTTTCCCCGCTTTT. The polymorphism
was genotyped in all twins DNA as well as in 114 unrelated PBC cases and 118 controls for
further confirmation.
Statistical analysis—Consistency for transcription data among MZ twin sets was defined
as a consistent up- or down-regulation of specific genes observed in 3 out of 4 affected twins
compared to their healthy counterpart among discordant sets. We also analyzed the
transcription profiles between concordant twins and 20 pairs of PBC discordant sisters as a
stringent criterion for consistency (see example in Supplementary Fig. 1). SNP frequencies
were compared between patients with PBC and controls using the chi-square test. All
statistical analyses were performed using Intercooled Stata 8.0 (Stata Corporation, College
Station, TX) and SAS (SAS Institute Inc., Cary, NC).
RESULTS
Gene transcription data
Normalized transcription data were analyzed by and sorted using linearized values from the
weakest normalized calibrator to identify consistent genes that were either significantly up-
or down-regulated in the affected twin compared to the healthy twin (Supplementary Table
2). While none of the variable XCI genes were consistently dysregulated in all 4 pairs of
discordant PBC twin pairs, two transcripts (CLIC2 and PIN4) were found to be consistently
dysregulated in 3 out of 4 discordant sets while with similar transcription profiles in the
concordant set of twins (Table 1).
CLIC2 promoter methylation
DNA methylation was examined for the CLIC2 promoter that lacks a CpG island
(http://genome.ucsc.edu, CpG island track). Bisulfite sequencing primers were designed to a
279 bp region 5’ of the transcription start site containing 6 CpG sites (Figure 1A). CLIC2
bisulfite sequencing data was calculated by 5 MZ twin sets, one concordant and 4 discordant
for PBC, each with a minimum of 20 clones. Methylation patterns of individually sequenced
clones are shown for a representative discordant twin pair in Figure 1B, with circles
representing CpG sites that are methylated (filled) or unmethylated (open). Variable
methylation patterns were observed between individual clones and individual CpG sites for
all samples (Supplementary Figure 1). Overall promoter methylation was determined as the
percentage of methylated CpG sites out of all possible CpG sites while site-specific
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methylation was calculated for each of the 6 CpG sites in the CLIC2 promoter region for
each sample (Table 1). Percent methylation calculations were then grouped according to
diagnosis (mean ± SEM) and tested for significance by t-test. CLIC2 showed partial
promoter methylation ranging from 44 to 67% of available CpG sites and no significant
differences in percent methylation for overall promoter methylation (Figure 1C) or site-
specific methylation (Figure 1D) were observed between healthy and PBC twins. Transcript
levels of CLIC2 did not significantly correlate with overall promoter methylation (Figure
1E).
PIN4 promoter genotyping and methylation
PIN4 lacks a CpG island at its promoter, but bisulfite sequencing primers were designed to
span 11–13 CpG sites covering 221 bp including part of exon 1 (Figure 2A). This promoter
region contains two linked SNPs at predicted CpG sites 7 and 8. Both SNPs change the
predicted CG to AG resulting in 11 CpGs rather than 13 CpGs for the less common allele
(polymorphic sites are colored green and red in Figure 2B). PIN4 alleles are defined as allele
1 (including 11 CpG sites) or allele 2 (13 CpG sites) based on ss10563357, dbSNP (Figure
2C–G). All twin pair DNA samples were genotyped and were homozygous for allele 1
except for twin set 54, 55 who were heterozygous for both alleles (Table 1). The genotype
frequencies observed were consistent with the NCBI database with the majority of the
population homozygous for allele 1, a small percentage heterozygous, and zero of the
population homozygous for allele 2 (Table 2). PIN4 promoter methylation was analyzed
separately for the two alleles since the polymorphisms affect CpG sites. Only one of the
PBC twin pairs was heterozygous for ss10563357, but no apparent or significant difference
was observed in methylation patterns between the healthy and PBC twin (Figure 2B, E).
Grouped overall percent methylation of both alleles were determined as the total number
methylated sites out of the total possible sites (Figure 2C for allele 1, 2F for allele 2).
Individual CpG site percent methylation of the two alleles in the PIN4 promoter also showed
no significant differences between healthy and PBC subjects (Figure 2D for allele 1, 2G for
allele 2). Conversely, transcription analysis of PIN4 demonstrated a trend for increased
transcription correlating with increased methylation in allele 1 (Figure 2H) that was not
statistically significant.
CLIC2 and PIN4 X chromosome inactivation status
While the individual clones from bisulfite sequencing of both CLIC2 and PIN4 promoters
did not appear to distinguish active and inactive X chromosome alleles, we tested this
hypothesis formally using an approach previously described for promoters of XCI subject
genes MECP2 and AR12. Bisufite sequencing of AR was used as a control for XCI status in
twins as this is a known gene subject to XCI in females and used for clinical XCI assays13.
The XCI status of each allele was illustrated with the comparison of the number of
methylated CpG sites per clone compared to the percentage of the total clones. XA (active
X) represents the frequency of bisulfite clones with no methylated CpG sites while XI
(inactive X) represents the bisulfite clones with greater than 50% methylation of the CpG
sites in a given clone designated as the inactivated alleles. X? represents bisulfite clones with
greater than 0% and less than 50% methylated CpGs that cannot be classified as activated or
repressed (Figure 3). In addition to the MZ twin cohort, two healthy female and two health
male controls with no familial history of PBC or other autoimmune disease history were
included. Both males showed no XCI for AR as expected, with 90% of the clones having
zero methylation and only 10% with one methylated site. Female controls showed the
typical bi-modal distribution of XA and XI alleles of AR seen in Figure 3A, with very few
clones in the X? category. The healthy and PBC female twins show a similar pattern of XCI
status as the female controls and do not present aberrant XCI at the AR promoter. Figure 3B,
C illustrates the XCI status of the CLIC2 and PIN4 promoter regions in which a bimodal
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distribution into XA and XI alleles is not observed. Unlike AR that contains a CpG island and
is always subject to XCI, CLIC2 and PIN4 both show approximately one third of bisulfite
sequenced clones as of X? alleles that cannot be designated as active or inactive.
DISCUSSION
PBC is an autoimmune disease commonly referred to as a model for understanding the
pathogenesis of autoimmunity based on its uniform features including female prevalence
and clinical presentation. While genetic factors are of seminal importance in determining
disease susceptibility, these can be confirmed only in subgroups of patients14 and could not
explain the imbalanced sex ratio. We previously observed that women with PBC manifest an
enhanced rate of preferential X monosomy but random XCI in their peripheral lymphocytes
compared to age-matched women5, 6. In this study we thus tested the hypothesis that X-
linked promoters, particularly those of variable XCI genes may be dysregulated through
aberrations in promoter methylation and utilized the unique model of clinically discordant
MZ twin pairs. From this analysis, we identified two candidate genes CLIC2 and PIN4 that
exhibited decreased transcription in 3 out of 4 affected compared to healthy twins in
discordant twin pairs. However, for both CLIC2 and PIN4 promoters, methylation was
partial, variable and did not predict either XCI status or transcript levels. These results are
informative both for future studies into understanding genetics and epigenetics of PBC as
well as the epigenetic characteristics of genes that escape XCI in human females.
Although DNA methylation has been associated with a variety of diseases and disorders;
specific patterns of DNA methylation in gene promoters and nonrepetitive genomic regions
are remarkably similar between unrelated individuals15–18. In addition, methylation
profiles between male and female autosomes are also highly similar17. A recent large scale
sequencing of the genome and epigenome of twin pairs with mutiple sclerosis has also
demonstrated that methylated CpG sites within CpG islands (MspI fragments) are nearly
identical in the same tissue (CD4+ T cells) compared between twins, only slightly more
variable between unrelated individuals, and most variable between different tissues or tumor
versus normal tissue19. Moreover, Javierre and colleagues recently studied the methylation
status of a cohort of MZ twins discordant for three autoimmune diseases: systemic lupus
erythematosus (SLE), rheumatoid arthritis, and dermatomyositis; only MZ twins discordant
for SLE featured widespread changes in the DNA methylation status of a significant number
of genes20. However, while most DNA methylation studies focus on CpG island and
promoters, genome-wide epigenomic studies have reinstated that gene promoters are vastly
de-enriched for DNA methylation, while methylation of intergenic and repetitive regions is
extensive21–24.
Several reports have linked epigenetics to disease phenotypes in humans. One example
includes the incidence of discordant MZ twins for the X-linked dominant disorder Rett
syndrome where discordance was due to differences in skewed XCI25, 26. Methylation at
one particular CpG site upstream of the MECP2 promoter has been shown to be
significantly increased in male autism subjects compared to controls27. In schizophrenia
samples, hypermethylation of the reelin gene (RLN) promoter CpG island has been
observed28. It is also noteworthy that discordance in MZ twin pairs for Beckwith-
Wiedemann syndrome is due to differences in imprinting of the KCNQ1OT1 gene29. In
addition, differences to methylation patterns to the imprinted gene H19 correlates to
discordance of MZ twins for Silver-Russell syndrome30. While there is also evidence of
epigenetic mechanisms in animal models for the autoimmune disease systemic lupus
erythematosus31, 32 we note that cells to be investigated for epigenetic changes may include
target or effecter cell populations thus introducing an additional confounding factor.
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While CLIC2 and PIN4 are dysregulated in most discordant PBC twin pairs, the mechanism
behind the variant transcript levels does not appear to be promoter methylation. Genomic
evidence has suggested that X-linked genes lacking a CpG island may not be ‘classically’
regulated by promoter methylation33. In addition, PCR-based methylation analyses of the
known XCI escape gene MAOA, encoding monoamine oxidase A, has shown a similar
pattern of variable promoter methylation not associated with transcription or XCI status34.
The bisufite sequencing based XCI status categorization approach performed here and
described for XCI subject genes previously12 may be useful for future studies investigating
promoter methylation patterns for genes that escape XCI. While genetic polymorphisms
within or close to promoters have been hypothesized to be responsible for the variability in
XCI status of specific genes, our preliminary analysis of a known polymorphism creating
two additional CpG sites in the PIN4 promoter did not apparently affect overall promoter
methylation or transcription. Perhaps polymorphic repetitive elements may be an unexplored
genetic component affecting transcription and XCI status of X-linked genes in human.
CLIC2, chloride intracellular channel gene 2, was first suggested as a possible candidate for
one of the many diseases linked to chromosomal region Xq28 because previous findings
showed other human chloride channel genes had a direct association to a wide range of
hereditary diseases35. More recent work demonstrated that CLIC2 modulated intracellular
Ca2+ homeostasis through ryanodine receptors (RyR), suggesting that CLIC2 may alter the
calcium homeostasis of any tissue through RyR36. CLIC2 dysregulation could possibly be
causing aberrations in calcium levels in the liver resulting in the degradation of the tissue,
ultimately leading to disease.
PIN4 is part of the parvulin family of peptdylprolyl cis/trans isomerases and has been shown
to be involved in mitotic regulatory mechanisms and cell proliferation37, 38. More
interesting, however, is a previous study has showing PIN4 is involved in chromatin
remodeling, an epigenetic mechanism involving ATP dependent changes to histone
modifications39. PIN4 dysregulation could therefore affect chromatin remodeling altering
transcription and regulation of multiple susceptibility or protective genes for PBC.
The major challenges for the future of epigenetic studies in human disease outcome is in
identifying regions of the genome to investigate for DNA methylation differences relevant
to gene transcription and to develop novel methods for identifying DNA methylation
patterns that correlated with disease outcome. MZ twin studies of discordant disease are
expected to continue to be of use in separating genetic from epigenetic variables in such
studies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported by the American Liver Foundation (C.S.), NIH R21DK075400 (C.S.) and R01ES015171
(J.M.L.). The authors thank the PBCers organization for continuous support.
References
1. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a
new center of gravity, and prime time for autoimmunity. J Autoimmun 2008;31:325–330. [PubMed:
18838248]
2. Selmi C, Zuin M, Gershwin ME. The unfinished business of primary biliary cirrhosis. J Hepatol
2008;49:451–460. [PubMed: 18640737]
Mitchell et al. Page 7













3. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex?
Autoimmun Rev 2008;7:626–630. [PubMed: 18603021]
4. Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome
defects in autoimmune diseases. J Autoimmun 2009;33:12–16. [PubMed: 19356902]
5. Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, et al. Frequency of
monosomy X in women with primary biliary cirrhosis. Lancet 2004;363:533–535. [PubMed:
14975617]
6. Miozzo M, Selmi C, Gentilin B, Grati FR, Sirchia S, Oertelt S, et al. Preferential X chromosome
loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007;46:456–462.
[PubMed: 17659578]
7. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in
monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology
2004;127:485–492. [PubMed: 15300581]
8. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise
during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005;102:10604–10609.
[PubMed: 16009939]
9. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene
expression in females. Nature 2005;434:400–404. [PubMed: 15772666]
10. Clay CC, Rodrigues DS, Brignolo LL, Spinner A, Tarara RP, Plopper CG, et al. Chemokine
networks and in vivo T-lymphocyte trafficking in nonhuman primates. J Immunol Methods
2004;293:23–42. [PubMed: 15541274]
11. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics
2002;18:1427–1431. [PubMed: 12424112]
12. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, et al. MECP2
promoter methylation and X chromosome inactivation in autism. Autism Res 2008;1:169–178.
[PubMed: 19132145]
13. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI
sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X
chromosome inactivation. Am J Hum Genet 1992;51:1229–1239. [PubMed: 1281384]
14. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary biliary cirrhosis associated with
HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009;360:2544–2555. [PubMed: 19458352]
15. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, et al. Epigenetic profiling
of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA
methylation patterns. Hum Mol Genet 2009;18:4808–4817. [PubMed: 19776032]
16. Grunau C, Hindermann W, Rosenthal A. Large-scale methylation analysis of human genomic
DNA reveals tissue-specific differences between the methylation profiles of genes and
pseudogenes. Hum Mol Genet 2000;9:2651–2663. [PubMed: 11063724]
17. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science
2007;315:1141–1143. [PubMed: 17322062]
18. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, et al. DNA
methylation signatures within the human brain. Am J Hum Genet 2007;81:1304–1315. [PubMed:
17999367]
19. Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, et al.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Nature 2010;464:1351–1356. [PubMed: 20428171]
20. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et
al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus
erythematosus. Genome Res 2010;20:170–179. [PubMed: 20028698]
21. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon
cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG
island shores. Nat Genet 2009;41:178–186. [PubMed: 19151715]
22. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA
methylomes at base resolution show widespread epigenomic differences. Nature. 2009
Mitchell et al. Page 8













23. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP. A human B cell methylome at 100-base pair
resolution. Proc Natl Acad Sci U S A 2009;106:671–678. [PubMed: 19139413]
24. Rollins RA, Haghighi F, Edwards JR, Das R, Zhang MQ, Ju J, et al. Large-scale structure of
genomic methylation patterns. Genome Res 2006;16:157–163. [PubMed: 16365381]
25. Bruck I, Philippart M, Giraldi D, Antoniuk S. Difference in early development of presumed
monozygotic twins with Rett syndrome. Am J Med Genet 1991;39:415–417. [PubMed: 1715129]
26. Migeon BR, Dunn MA, Thomas G, Schmeckpeper BJ, Naidu S. Studies of X inactivation and
isodisomy in twins provide further evidence that the X chromosome is not involved in Rett
syndrome. Am J Hum Genet 1995;56:647–653. [PubMed: 7887418]
27. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is
frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.
Epigenetics 2006;1:e1–e11. [PubMed: 17486179]
28. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, et al. Reelin promoter
hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 2005;102:9341–9346. [PubMed:
15961543]
29. Weksberg R, Shuman C, Caluseriu O, Smith AC, Fei YL, Nishikawa J, et al. Discordant
KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann
syndrome. Hum Mol Genet 2002;11:1317–1325. [PubMed: 12019213]
30. Yamazawa K, Kagami M, Fukami M, Matsubara K, Ogata T. Monozygotic female twins
discordant for Silver-Russell syndrome and hypomethylation of the H19-DMR. J Hum Genet
2008;53:950–955. [PubMed: 18709478]
31. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007;3:521–527.
[PubMed: 17762851]
32. Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y, et al. DNA
methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006;6:99–106.
[PubMed: 17061057]
33. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al. Chromosome-wide and
promoter-specific analyses identify sites of differential DNA methylation in normal and
transformed human cells. Nat Genet 2005;37:853–862. [PubMed: 16007088]
34. Pinsonneault JK, Papp AC, Sadee W. Allelic mRNA expression of X-linked monoamine oxidase a
(MAOA) in human brain: dissection of epigenetic and genetic factors. Hum Mol Genet
2006;15:2636–2649. [PubMed: 16893905]
35. Heiss NS, Poustka A. Genomic structure of a novel chloride channel gene, CLIC2, in Xq28.
Genomics 1997;45:224–228. [PubMed: 9339381]
36. Board PG, Coggan M, Watson S, Gage PW, Dulhunty AF. CLIC-2 modulates cardiac ryanodine
receptor Ca2+ release channels. Int J Biochem Cell Biol 2004;36:1599–1612. [PubMed:
15147738]
37. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of
mitosis. Nature 1996;380:544–547. [PubMed: 8606777]
38. Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, et al. Pin1 and Par14
peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 2003;10:15–24. [PubMed:
12573694]
39. Surmacz TA, Bayer E, Rahfeld JU, Fischer G, Bayer P. The N-terminal basic domain of human
parvulin hPar14 is responsible for the entry to the nucleus and high-affinity DNA-binding. J Mol
Biol 2002;321:235–247. [PubMed: 12144781]
Mitchell et al. Page 9













Figure 1. CLIC2 bisulfite sequencing for promoter methylation analysis
A) Chromosomal sequence location of the region of the CLIC2 promoter that was analyzed
by bisulfite sequencing. This region contains 6 CpG sites (circles) within a 279 bp region
overlapping the transcription start site as shown. B) Representative bisulfite sequencing data
from a PBC discordant twin pair. Each circle represents a CpG site and each line represents
an individually sequenced clone. Filled circles represent methylated sites (protected from
bisulfite conversion) while unfilled circles represent unmethylated CpG sites (converted). C)
Overall percent methylation was determined by the total number methylated sites out of the
total CpG sites in all clones and graphed as mean ± SEM for PBC (n=6) versus healthy
(n=4) samples. D) Percent methylation was calculated for each individual site within the
CLIC2 promoter region for all clones and represented as mean ± SEM for PBC (n=6) versus
healthy (n=4) samples. E) Analysis of CLIC2 promoter methylation versus transcription for
each individual sample. Each twin pair is represented by an individual symbol, as shown,
with filled symbols representing PBC and open symbols representing healthy individuals of
each twin pair. No significant correlation was observed between CLIC2 promoter
methylation and transcription.
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Figure 2. Bisulfite sequencing analysis of PIN4 promoter methylation and genotype
A) Chromosomal sequence location of the region of the PIN4 promoter that was analyzed by
bisulfite sequencing. This region contains 11 or 13 CpG sites dependent on SNP:
ss10563357. All samples were homozygous for allele 1 (11 CpG sites, AG at sites 7 and 8)
except for one discordant twin set heterozygous for alleles 1 and 2 (allele 2 has 13 CpG
sites). B, E) Bisulfite sequencing results for the heterozygous twin pair 54 and 55. Results
are exhibited as in panel 1B except red and green filled circles represent CG sites absent in
allele 1 and the two alleles are grouped separately as allele 1 (B) and allele 2 (E). DNA
methylation patterns were variable between clones, alleles, and twins, but no apparent
association was observed between PBC status or allele status and DNA methylation. C, F)
Overall percent methylation of allele 1(C) or allele 2 (F) was determined and graphed as
mean ± SEM of all available samples. D,G) Site specific analysis of individual CpG sites in
the PIN4 promoter of allele 1(D) or allele 2 (G) was determined and graphed as mean ±
SEM of all available samples. H) Analysis of PIN4 promoter methylation versus
transcription for each individual sample. Each twin pair is represented by an individual
symbol, as shown, with filled symbols representing PBC and open symbols representing
healthy individuals of each twin pair; black symbols representing allele 1 and red symbols
representing allele 2. Allele 1 of PIN4 showed a trend for increased transcription with
increased methylation that was not siginificant, while allele 2 did not show an apparent
correlation between transcription and methylation.
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Figure 3. Determination of XCI allele status from bisulfite sequencing analyses
A–C) Each clone from bisulfite sequencing was analyzed for the number of CpG sites
methylated in each clone. Histograms represent the distribution of percentage of clones
based on degree of methylation. The bimodal peaks observed at all three loci are consistent
with X chromosome inactivation. Clones with no sites methylated are designated as clear
active alleles (XA), clones with >50% of maximum number of methylated sites are
designated as inactive (XI), and the intervening clones as potentially undefined XCI status
(X?). A) The control X inactivated gene AR has a maximum of 9 possible methylation sites.
Both male controls had no XI clones, as expected, with 90% of the clones showing no
methylated sites and only one clone showing one methylated CpG site. Female controls
showed the typical bimodal distribution into active and inactive alleles. Individuals within
the PBC twin pairs showed a similar bimodal distribution with no apparent differences
between XA and XI alleles at the AR promoter. B) Unlike AR, the XCI allele distribution of
CLIC2 methylation patterns did not follow a bimodal distribution typical of promoters
subject to XCI. Approximately 40% of clones at CLIC2 fell into the X? status category that
could not be designated as active or inactive. No apparent differences were observed
between healthy and PBC individuals in the XCI status distribution. C) The PIN4
methylation pattern also did not fit the typical XCI distribution pattern, as 20–30% of the
clones fell within the X? category. Both healthy and PBC subjects showed similar
frequencies of X? clones.
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Table 2
PIN4 genotyping of SNP Rs7058353 in unrelated patients with PBC and controls and in 20 sets of sisters of
similar age discordant for PBC. The presence of this SNP determines 11 CpG sites, instead of the original 13.
Gentoype and allele frequencies did not differ significantly between patients and related or unrelated controls.
PBC Controls
Unrelated subjects
 C/C 3/114 0/118
 C/A 9/114 7/118
 A/A* 102/114 111/118
 A allele frequency 0.934 0.970
Siblings
 C/C 0/20 0/20
 C/A 2/20 2/20
 A/A* 18/20 18/20
 A allele frequency 0.950 0.950
*
Allele frequency in Caucasian-European population 0.966 (NCBI SNP database)
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